Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Pierre Gestraud

12PUBLICATIONS
126CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Innate immunityCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

Sort by Publication Date:
|Sep 10, 2025
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis.

Abderaouf Hamza, Pierre Gestraud, Maryam Karimi

|Aug 01, 2024
Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors.

Marie-Paule Sablin, Pierre Gestraud, Sarah Flora Jonas

|Jul 18, 2024
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort.

Nicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon

|Jan 04, 2024
DNA methylation restricts coordinated germline and neural fates in embryonic stem cell differentiation.

Mathieu Schulz, Aurélie Teissandier, Elena De La Mata Santaella

|Apr 26, 2023
A druggable copper-signalling pathway that drives inflammation.

Stéphanie Solier, Sebastian Müller, Tatiana Cañeque

|Jan 05, 2023
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.

Elizabeth R Tucker, Irene Jiménez, Lindi Chen

Pageof 2

Frequent Collaborators

4 joint publications

Christophe Le Tourneau

3 joint publications

Marta Jimenez

3 joint publications

Nicolas Servant

3 joint publications

Fabrice Andre

2 joint publications

Elaine Del Nery

2 joint publications

Maud Kamal

2 joint publications

Stefan Michiels

2 joint publications

Ludovic Lacroix

2 joint publications

Sarah Watson

1 joint publications

Ivan Bièche

Frequent Collaborators

4 joint publications

Christophe Le Tourneau

3 joint publications

Marta Jimenez

3 joint publications

Nicolas Servant

3 joint publications

Fabrice Andre

Top Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

25.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.2K
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on : Apr 12, 2017

13.6K
See more related videos

Top Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

25.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.2K
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on : Apr 12, 2017

13.6K
See more related videos